Northwest Biotherapeutics Inc. (NWBO) Jumps 15.99% on February 16

Equities Staff |

Northwest Biotherapeutics Inc. (NWBO) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 15.99% to $2.29, representing a gain of $0.315 per share. Some 278,912 shares traded hands on 1,162 trades, compared with an average daily volume of 481,632 shares out of a total float of 92.36 million. The stock opened at $2.00 and traded with an intraday range of $2.32 to $2.00.

After today's gains, Northwest Biotherapeutics Inc. reached a market cap of $211.04 million. Northwest Biotherapeutics Inc. has had a trading range between $12.55 and $1.85 over the last year, and it had a 50-day SMA of $2.98 and a 200-day SMA of $6.77.

Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.

Northwest Biotherapeutics Inc. is based out of Bethesda, MD and has some 12 employees. Its CEO is Linda F Powers.

For a complete fundamental analysis analysis of Northwest Biotherapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for NWBO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…